Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery
Conditions
- Adult Solid Neoplasm
- Recurrent Ovarian Carcinoma
- Recurrent Uterine Corpus Carcinoma
- Stage III Ovarian Cancer AJCC v6 and v7
- Stage III Uterine Corpus Cancer AJCC v7
- Stage IV Ovarian Cancer AJCC v6 and v7
- Stage IV Uterine Corpus Cancer AJCC v7
Interventions
- DRUG: Eribulin Mesylate
- DRUG: Gemcitabine Hydrochloride
Sponsor
National Cancer Institute (NCI)